Fennec Pharmaceuticals Inc.
FENC
$6.01
-$0.27-4.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.99M | -5.74M | -5.55M | 12.84M | -2.68M |
| Total Depreciation and Amortization | -774.00K | 25.00K | 26.00K | 723.00K | -- |
| Total Amortization of Deferred Charges | 895.00K | 21.00K | 23.00K | 20.00K | 70.00K |
| Total Other Non-Cash Items | 338.00K | 6.25M | 1.33M | 1.60M | 176.00K |
| Change in Net Operating Assets | 52.00K | -2.76M | -4.21M | 23.87M | -2.42M |
| Cash from Operations | -1.47M | -2.21M | -8.39M | 39.05M | -4.86M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 5.00M |
| Total Debt Repaid | -13.00M | -- | -- | -- | -- |
| Issuance of Common Stock | 797.00K | -- | 347.00K | 627.00K | 747.00K |
| Repurchase of Common Stock | -9.00K | -528.00K | -90.00K | -19.00K | -17.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | -1.74M | -- |
| Cash from Financing | -12.21M | -528.00K | 257.00K | -1.13M | 5.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.69M | -2.73M | -8.13M | 37.92M | 870.00K |